BioLargo's Odor-No-More Gains More Traction With Its Largest Government Order to Date
SANTA ANA, CA--(Marketwired - Sep 23, 2014) - BioLargo , Inc. ( OTCQB : BLGO ) announced today its Odor-No-More subsidiary was awarded a contract for 885 cases (total order approximately $50,000) of its Specimen Transport Solidifier Pouches from the DLA U.S. Defense Logistics Agency (DLA - www.dla.mil ), through its distributor Downeast Logistics. The Specimen Transport Solidifiers are small absorbent pouches containing BioLargo's patent-protected technology and sold under the "NBS" brand. They and are used by the military as a safety measure in the event of a spill during the transport of blood, urine and other hazardous medical liquids. The company is producing the products for the order, and plans to fulfill the order in early October. This is the largest of many small orders from the DLA.
Additionally, the company has received initial orders for its Suction Canister Solidifiers for troop deployment kits (Assemblages) as well as new orders and reorders from multiple MMFs (Military Medical Facilities), including but not limited to the Langley and Fort Knox hospitals.
Odor-No-More has also received a series of small opening orders for "private label" products in which each customer plans to sell products containing BioLargo's patented technology under their own brand. The products are being resold into the Janitorial, Hospitality and Pet Products industries in the U.S. as well as other countries. More Private Label projects are in the works.
Dennis Calvert, President & CEO of BioLargo commented, "These are just a few examples of how our odor-control technology is finding its way to market. Our investment of time and money in advancing our technology, and refining our products, has enabled us to create top-performing and award-winning products. We are encouraged and each of these small steps helps to expand our business and opens new opportunities for sales and new products."
About BioLargo, Inc.
BioLargo, Inc. ( OTCQB : BLGO ) makes life better by delivering technology-based products that help solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com . The subsidiary BioLargo Water, Inc. ( www.BioLargoWater.com ) showcases the Advanced Oxidation Systems, including its AOS Filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project. The subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature's Best Solution® and Deodorall® brands. ( www.OdorNoMore.com ). The subsidiary Clyra Medical Technologies, Inc. ( www.ClyraMedical.com ), focuses on advanced wound care management and is preparing to make FDA 510(k) applications in 2015.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K for the year ended December 31, 2013.
Company contact:
Dennis Calvert
President
BioLargo, Inc. 949-643-9540 x1
